Maximize your treatment of alcohol-associated liver disease. Learn how to evaluate liver disease in patients with alcohol use disorder (AUD), choose AUD medications that are safe and effective, and identify patients who may be eligible for early liver transplantation. We’re joined by Dr. Lamia Haque, @lykhaque (Yale School of Medicine).

We are thrilled to produce Season 3 with support and partnership from The American College of Academic Addiction Medicine (ACAAM)!

Claim CME for this episode at !
By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education.

Episodes | Subscribe | Spotify | iTunes | CurbsidersAddictionMed@gmail.com | Free CME!

Show Segments

  • Intro, disclaimer, guest bio 0:00 
  • Guest one-liner 3:10
  • Case from Kashlak 6:30
  • Epidemiology of alcohol-associated liver disease (ALD) 7:40
  • How does alcohol affect the liver? 11:11
  • Spectrum of ALD 13:10
  • Risk factors for ALD 16:13
  • Evaluating for ALD 19:35
  • When to refer to hepatology 33:08
  • Medications for AUD in patients with ALD 37:00
  • Monitoring liver tests for naltrexone 44:27
  • Optimizing treatment for patients who continue drinking 47:18
  • ALD and liver transplantation 50:45
  • Post-transplant care 1:00:15
  • Take-home points 1:02:30
  • Outro 1:04:56
Credits

  • Writer and Producer: Kenneth Morford, MD
  • Show Notes: Kenneth Morford, MD
  • Infographic and Cover Art: Natalie Stahl, MD, MPH
  • Hosts: Carolyn Chan, MD. MHS and Kenneth Morford, MD
  • Reviewer: Sarah Leyde, MD
  • Showrunner: Carolyn Chan, MD, MHS
  • Technical Production: PodPaste
  • Guest: Lamia Haque, MD, MPH

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör The Curbsiders Addiction Medicine Podcast. Innehållet i podden är skapat av The Curbsiders Addiction Medicine Podcast och inte av, eller tillsammans med, Poddtoppen.